Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients-Reference-Cited by-同舟云学术

Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients

Published:2018-12 Issue:12 Volume:20 Page:1652-1662
ISSN:1098-3600
Container-title:Genetics in Medicine
language:en
Short-container-title:Genetics in Medicine

Author:

Calsina Bruna,Currás-Freixes Maria,Buffet Alexandre,Pons Tirso,Contreras Laura,Letón Rocío,Comino-Méndez Iñaki,Remacha Laura,Calatayud María,Obispo Berta,Martin Antoine,Cohen Regis,Richter Susan,Balmaña Judith,Korpershoek Esther,Rapizzi Elena,Deutschbein Timo,Vroonen Laurent,Favier Judith,de Krijger Ronald R.,Fassnacht Martin,Beuschlein Felix,Timmers Henri J.,Eisenhofer Graeme,Mannelli Massimo,Pacak Karel,Satrústegui Jorgina,Rodríguez-Antona Cristina,Amar Laurence,Cascón Alberto,Dölker Nicole,Gimenez-Roqueplo Anne-Paule,Robledo Mercedes

Publisher

Elsevier BV

Subject

Genetics (clinical)

Link

http://www.nature.com/articles/s41436-018-0068-7.pdf

Reference40 articles.

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and molecular markers guide the genetics of pheochromocytoma and paraganglioma;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Molecular genetics of pheochromocytoma/paraganglioma;Current Opinion in Endocrine and Metabolic Research;2024-09

3. Genetics of MDH in humans;Essays in Biochemistry;2024-07-22

4. Physiology of malate dehydrogenase and how dysregulation leads to disease;Essays in Biochemistry;2024-07-04

5. Malate dehydrogenase (MDH) in cancer: a promiscuous enzyme, a redox regulator, and a metabolic co-conspirator;Essays in Biochemistry;2024-06-12